Fractalkine over expression suppresses α-synuclein-mediated neurodegeneration.
Nash, Kevin R
Fractalkine over expression suppresses α-synuclein-mediated neurodegeneration. [electronic resource] - Molecular therapy : the journal of the American Society of Gene Therapy Jan 2015 - 17-23 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1525-0024
10.1038/mt.2014.175 doi
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Animals
Antigen Presentation
Astrocytes--metabolism
Chemokine CX3CL1--agonists
Dependovirus--genetics
Gene Expression Regulation
Genetic Therapy--methods
Genetic Vectors
Glial Fibrillary Acidic Protein
Histocompatibility Antigens Class II--genetics
Male
Mice
Microglia--metabolism
Nerve Tissue Proteins--genetics
Neurons--metabolism
Oxidopamine
Parkinson Disease, Secondary--chemically induced
Parkinsonian Disorders--genetics
Promoter Regions, Genetic
Rats
Signal Transduction
Substantia Nigra--metabolism
Tyrosine 3-Monooxygenase--genetics
alpha-Synuclein--antagonists & inhibitors
Fractalkine over expression suppresses α-synuclein-mediated neurodegeneration. [electronic resource] - Molecular therapy : the journal of the American Society of Gene Therapy Jan 2015 - 17-23 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1525-0024
10.1038/mt.2014.175 doi
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Animals
Antigen Presentation
Astrocytes--metabolism
Chemokine CX3CL1--agonists
Dependovirus--genetics
Gene Expression Regulation
Genetic Therapy--methods
Genetic Vectors
Glial Fibrillary Acidic Protein
Histocompatibility Antigens Class II--genetics
Male
Mice
Microglia--metabolism
Nerve Tissue Proteins--genetics
Neurons--metabolism
Oxidopamine
Parkinson Disease, Secondary--chemically induced
Parkinsonian Disorders--genetics
Promoter Regions, Genetic
Rats
Signal Transduction
Substantia Nigra--metabolism
Tyrosine 3-Monooxygenase--genetics
alpha-Synuclein--antagonists & inhibitors